Blue Shield of California is a nonprofit insurer
Selective myostatin inhibition by apitegromab resulted in a 54.9% retention of lean mass relative to placebo, with similar total weight loss between treatment arms, indicating preservation of lean mass in the context of GLP-1 weight management
100,000+ Happy Customers May support healthy weight management when combined with lifestyle changes Can help promote balanced appetite and fullness cues May assist with healthy metabolic function Designed for convenient, once-weekly use under medical supervision Multiple Delivery Options Medical-Grade Ingredients Targeted Appetite & Metabolic Support Medical weight-management programs use GLP-1based treatments that act on hormone pathways related to appetite, digestion, and metabolic regulation
New Weight Loss Treatment Approved by the FDA Are you looking to shed some unwanted pounds and improve your overall health and well-being
No gluten, yeast, wheat, milk or milk derivatives, lactose, sugar, preservatives, soy, artificial color, artificial flavor, sodium (less than 5 mg per serving)
